Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.
about
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsEvidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitPharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?Patent ductus arteriosus in premature neonates.Patent ductus arteriosus in preterm infants: do we have the right answers?Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?Quintuplets: 5 Cases of NEC. Are There Other Risk Factors?The persistently patent arterial duct in the premature infant.Predictors of successful closure of patent ductus arteriosus with indomethacin.Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids.Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis.Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
P2860
Q24235550-CED0CBF0-454A-433D-BE71-FD01AC16792AQ24244935-E471CFDA-9CD5-4A08-94F4-EE596C85A957Q24604121-E7842F85-BC94-4584-8010-2B59ED1A7354Q34517223-B3D26EEE-6425-457E-B72F-EC7F2C0956ABQ35577606-2BD7CF63-226D-4B67-A3E2-E604A8594B1EQ35580251-BBC61536-033F-4D78-9BD6-B957CCFFDDD1Q35607990-5B3CD689-E98F-4963-8DCA-DF761283B9B7Q37451050-05C7BD2A-50BA-4C6D-9BCA-724E73B98297Q37698200-CD40868C-6027-4DE2-9E3B-10D478C472D4Q38934707-F94CC2BD-3912-4DDA-BE3B-0046F0FDC4F8Q39652304-4FCB0CF0-FD7F-4358-A3AE-4BC15B56A000Q41097405-D0B1B19C-F8D8-4585-9264-FF096D0175BEQ46357507-FF7DE290-10E8-4D6D-8472-5E575BB53182Q48228247-B13F1C53-16D2-468A-9DFE-6BA1B8994CD6Q58800590-38CEAB8E-86B7-4D47-B94E-38E809978E36
P2860
Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@ast
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@en
type
label
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@ast
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@en
prefLabel
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@ast
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@en
P2093
P1476
Prophylactic indomethacin ther ...... rfactant in the delivery room.
@en
P2093
Cabalka AK
Ferrara TB
Hoekstra RE
Schilling CG
P304
P356
10.1016/S0022-3476(96)80127-2
P407
P433
P577
1996-05-01T00:00:00Z